bioRxivPharmacology & ToxicologyPreprint
Impact of juglone on oral carcinogenesis induced by 4-nitroquinoline-1-oxide (4NQO) in rat model
O. Topal, B. Topal, Y. Bas, B. Ongan, G. Sadi, E. Aslan, B. Demirciler Yavas, M. B. Pektas
Abstract
In this study, the potential effects of juglone, also known as PIN1 inhibitor, on oral cancer and carcinogenesis were investigated at the molecular level. 4-Nitroquinoline N-oxide (4-NQO) was used to create an oral cancer model on animals. Wistar rats were divided into five groups; Control, NQO, Juglone, NQO+J, and NQO+J*. The tongue tissues of the rats were isolated after the experiment, morphological changes were investigated by histological examinations, and the molecular apoptotic process was investigated by rt-qPCR and Western blot. Histological results indicate that tumors are formed in the tongue tissue with 4-NQO, and juglone treatment largely corrects the epithelial changes that developed with 4-NQO. It has been determined that apoptotic factors p53, Bax, and caspases are induced by the effect of juglone, while antiapoptotic factors such as Bcl-2 are suppressed. However, it was observed that the positive effects were more pronounced in rats given juglone together with 4-NQO. The use of PIN1 inhibitors such as juglone in place of existing therapeutic approaches might be a promising and novel approach to the preservation and treatment of oral cancer and carcinogenesis. However, further research is required to investigate the practical application of such inhibitors.
- organism: rat
- assay: bulk RNA-seq
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of isoplumbagin as a novel NQO1 substrate and anti-cancer quinone
Y.-C. Tsao, Y.-J. Chang, … L. Chen·bioRxiv·Apr 28, 2020
- Epithelial Ikkβ deletion modulates immune responses and the IFNγ/CXCL9 axis during early esophageal carcinogenesis
Nathan Hodge, Marie‐Pier Tétreault·CarcinogenesisPeer-reviewed·Sep 1, 2025
- Cancer vaccine attenuates carcinogen induced head and neck cancer with impaired early T cell response
Michihisa Kono, Masahiro Rokugo, … Ravindra Uppaluri·bioRxiv·Jun 26, 2024
- 1,4-dihydroxy Quininib Attenuates Growth of Colorectal Cancer Cells and Xenografts and Regulates the TIE-2 Signaling Pathway in Patient Tumours
C. T. Butler, S. Kennedy, … B. N. Kennedy·bioRxiv·Dec 21, 2018
- Quercetin as a Bitter Taste Receptor Agonist with Anticancer Effects in Head and Neck Cancer Cells
Gavin Turner, Sarah M. Sywanycz, … Ryan M. Carey·NutrientsPeer-reviewed·Oct 14, 2025
- Self-Assembled Nucleolipid G-Quadruplexes Act as Multitarget Decoys for Oncogene Suppression in Pancreatic Cancer
Faith Kivunga, Virginie Baylot, … Philippe Barthélémy·Scientific ReportsPeer-reviewed·Oct 7, 2026